Search results
GSK spinoff Haleon has no deals on immediate horizon
Reuters via Yahoo Finance· 1 year agoConsumer healthcare group Haleon's Chief Executive Brian McNamara said on Thursday he does not expect to announce any acquisitions or divestments...
FTSE 100: GSK raises guidance after strong demand for shingles vaccine
Yahoo Finance UK· 2 years agoSales of the Shingrix vaccine by GSK have more than doubled to £731m. Photo: Reuters/Loriene Perera...
GSK consumer spin-off Haleon floats in biggest London listing in a decade
The Independent via Yahoo News· 2 years agoGlaxoSmithKline’s consumer spin-off Haleon has floated on the London Stock Exchange in Europe’s...
Former GSK consumer health arm Haleon posts 16.1% jump in quarterly sales
Reuters via Yahoo Finance· 2 years agoLONDON (Reuters) -Haleon, the former consumer health arm of GSK, on Thursday reported a 16.1%...
Haleon believes it is not liable for any potential Zantac liabilities
Reuters via Yahoo Finance· 2 years agoLONDON (Reuters) -Haleon believes it is not liable for any claims that may arise from U.S....
GSK spin-off Haleon reports price hikes in Europe
The Independent via Yahoo News· 2 years agoSome over-the-counter drugs became more expensive in Europe, the Middle East, Africa and Latin America than elsewhere over recent months, new data...
Haleon Shares Pop After Rejecting Zantac Indemnification Requests From GSK, Pfizer
Benzinga via Yahoo Finance· 2 years agoHaleon Plc (NYSE: HLN) notified GSK Plc (NYSE: GSK) and Pfizer Inc (NYSE: PFE) that it had rejected...
Haleon reports strong revenue growth in first results since GSK split
The Independent via Yahoo News· 2 years agoHealthcare company Haleon has reported a double-digit hike in revenue and profits in the group’s...
Sensodyne maker Haleon sees 22% profit rise in first results since GSK demerger
Evening Standard via Yahoo News· 2 years agoIncreasing sales of healthcare brands including Panadol, Advil and Centrum pushed operating profits...
UPDATE 3-GSK spinoff Haleon forecasts 4-6% revenue growth in 2023
Reuters via Yahoo Finance· 1 year agoHaleon, the world's biggest standalone consumer health business with brands such as Sensodyne toothpaste and Advil painkillers, on Thursday forecast 4-6% organic revenue growth in 2023. In its ...